Last reviewed · How we verify
Huatuo Zaizao Pills
At a glance
| Generic name | Huatuo Zaizao Pills |
|---|---|
| Also known as | Huatuo Zaizao Wan |
| Sponsor | Huashan Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Clinical Study on Huatuo Zaizao Pills for Post-stroke Treatment (PHASE4)
- Efficacy Study of Huatuo Zaizao Pills in Improving of Neural Function in Acute Ischemic Stroke (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Huatuo Zaizao Pills CI brief — competitive landscape report
- Huatuo Zaizao Pills updates RSS · CI watch RSS
- Huashan Hospital portfolio CI